Lanzamiento Enero 2027

Metaanálisis2026Acceso abierto

Effects of <i>Withania somnifera</i> (Ashwagandha) Supplementation on Exercise Performance: A Systematic Review and Three-Level Meta-Analysis

Li X, Li H, Yao S, Hou Y, Chi A

Nutrients · 0 citas

Cómo se estudió

Diseño
Metaanálisis (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
National Education Science Planning Foundation of China

Según 1 financiador declarado y la declaración de financiación del texto completo.

Publicación

Publicado
2026-06-12 · Nutrients · vol. 18 · número 12 · pág. 1915
Editorial
Multidisciplinary Digital Publishing Institute
Citado
1 cita · más que el 95% de estudios similares · 4.3× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
71 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
Phytochemicals and Medicinal Plants · Mindfulness and Compassion Interventions · Hormonal and reproductive studies
Palabras clave
Withania somnifera, Placebo, Blinding, Aerobic exercise, Randomized controlled trial, Confidence interval, VO2 max, Cohort study
MeSH
humans, withania, plant extracts, dietary supplements, adolescent, adult, female, male, randomized controlled trials as topic, athletic performance, young adult

5 autores

  • Xiupeng Li🇨🇳Shaanxi Normal University
  • Hansen Li🇨🇳Sichuan Agricultural University
  • Shuqi Yao🇨🇳Shaanxi Normal University
  • Ying Hou🇨🇳Shaanxi Normal University
  • Aiping Chi🇨🇳 · autor de correspondenciaShaanxi Normal University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background/objectives

Evidence for herbal ergogenic aids remains uncertain, and ashwagandha trials span heterogeneous performance domains. This review evaluated oral Withania somnifera supplementation on exercise performance and explored participant-, outcome-, formulation-, and supplementation-related moderators.

Methods

PubMed, Web of Science, Cochrane Library, Embase, and SPORTDiscus-EBSCO were searched from inception to 1 April 2026. Eligible randomized controlled trials compared oral ashwagandha with placebo or control conditions and reported objective exercise-performance outcomes. Dependent effects were synthesized using restricted-maximum-likelihood three-level random-effects models; 95% prediction intervals, GRADE certainty ratings, subgroup analyses, and dose/duration meta-regressions were reported.

Results

Thirteen trials involving 599 participants contributed 79 effect sizes. Samples were mainly young adults or athletes; reported ages included one 18-40-year trial and one late-adolescent athlete cohort aged 17.4 ± 1.7 years. Trial-level sex composition was four male-only, one female-only, three mixed-sex, and five incompletely reported cohorts. Ashwagandha improved overall exercise performance on average (Hedges' g = 0.47, 95% CI [0.25, 0.69], p 2 = 60%; 95% prediction interval [-0.40, 1.33]), but the prediction interval crossed zero. Exercise type was the clearest moderator (P_between = 0.006): evidence was most consistent for aerobic endurance (g = 0.54, 95% CI [0.22, 0.85], p = 0.002), whereas strength effects were positive but uncertain and power or muscular endurance evidence remained sparse. Dose analyses were hypothesis-generating; 500-600 mg/day was the most evidence-supported extract-dose range.

Conclusions

Oral ashwagandha may improve selected exercise-performance outcomes, particularly aerobic endurance, but benefits are not uniform across contexts. Future trials should be preregistered, adequately powered, double-blind, formulation-standardized, sex-stratified, and include rigorous blinding checks, mechanistic endpoints, adverse-event monitoring, and sport-specific performance tests.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.